CStone Pharmaceuticals (2616.HK)

HKD 2.65

(-0.75%)

Net Debt Summary of CStone Pharmaceuticals

CStone Pharmaceuticals's latest annual net debt in 2023 was -633.22 Million CNY , down -132.47% from previous year.
CStone Pharmaceuticals's latest quarterly net debt in 2024 Q1 was -372.43 Million CNY , up 45.04% from previous quarter.
CStone Pharmaceuticals reported annual net debt of -272.39 Million CNY in 2022, up 52.09% from previous year.
CStone Pharmaceuticals reported annual net debt of -568.52 Million CNY in 2021, up 80.67% from previous year.
CStone Pharmaceuticals reported quarterly net debt of -372.43 Million CNY for 2024 Q2, up 7.58% from previous quarter.
CStone Pharmaceuticals reported quarterly net debt of -718.54 Million CNY for 2023 Q1, down -163.79% from previous quarter.

Annual Net Debt Chart of CStone Pharmaceuticals (2023 - 2016)

Historical Annual Net Debt of CStone Pharmaceuticals (2023 - 2016)

Year	Net Debt	Net Debt Growth
2023	-633.22 Million CNY	-132.47%
2022	-272.39 Million CNY	52.09%
2021	-568.52 Million CNY	80.67%
2020	-2.94 Billion CNY	-162.07%
2019	-1.12 Billion CNY	-59.99%
2018	-701.33 Million CNY	-741.03%
2017	-83.39 Million CNY	-40.06%
2016	-59.53 Million CNY	0.0%

Year	Net Debt	Net Debt Growth
2024 Q1	-372.43 Million CNY	45.04%
2024 Q2	-372.43 Million CNY	7.58%
2023 Q1	-718.54 Million CNY	-163.79%
2023 Q3	-666.55 Million CNY	7.24%
2023 Q2	-718.54 Million CNY	0.0%
2023 FY	-633.22 Million CNY	-132.47%
2023 Q4	-677.68 Million CNY	-1.67%
2022 Q1	-539.43 Million CNY	5.12%
2022 FY	-272.39 Million CNY	52.09%
2022 Q4	-272.39 Million CNY	11.77%
2022 Q3	-308.74 Million CNY	37.59%
2022 Q2	-494.66 Million CNY	8.3%
2021 Q4	-568.52 Million CNY	2.28%
2021 Q3	-581.77 Million CNY	75.24%
2021 FY	-568.52 Million CNY	80.67%
2021 Q1	-2.35 Billion CNY	19.77%
2021 Q2	-2.34 Billion CNY	0.41%
2020 Q1	-1.71 Billion CNY	-52.44%
2020 Q3	-2.94 Billion CNY	-72.59%
2020 Q2	-1.7 Billion CNY	0.09%
2020 FY	-2.94 Billion CNY	-162.07%
2020 Q4	-2.94 Billion CNY	0.29%
2019 Q3	-1.12 Billion CNY	31.87%
2019 FY	-1.12 Billion CNY	-59.99%
2019 Q4	-1.12 Billion CNY	0.39%
2019 Q2	-1.65 Billion CNY	0.35%
2019 Q1	-1.65 Billion CNY	-136.57%
2018 Q4	-701.33 Million CNY	4.5%
2018 Q1	545.26 Million CNY	753.87%
2018 Q3	-734.34 Million CNY	0.0%
2018 FY	-701.33 Million CNY	-741.03%
2017 FY	-83.39 Million CNY	-40.06%
2017 Q4	-83.39 Million CNY	0.0%
2016 FY	-59.53 Million CNY	0.0%

Peer Net Debt Comparison of CStone Pharmaceuticals

Name	Net Debt	Net Debt Difference
Uni-Bio Science Group Limited	-76.36 Million HKD	-729.162%
CK Life Sciences Int'l., (Holdings) Inc.	5.26 Billion HKD	112.023%